Tech Company Financing Transactions
AlloCure Funding Round
On 4/2/2012, AlloCure raised $25 million in Series B funding from Lundbeckfond Ventures, Novo Ventures and SV Health Investors.
Transaction Overview
Company Name
Announced On
4/2/2012
Transaction Type
Venture Equity
Amount
$25,000,000
Round
Series B
Investors
Proceeds Purpose
The company will use the financing to trials for its AC607 treatment for acute kidney injury.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
25 Corporate Dr. 360
Burlington, MA 01803
USA
Burlington, MA 01803
USA
Phone
Website
Email Address
Overview
AlloCure is focused on developing cell therapies for the treatment of various kidney diseases, organ transplants, and multi-organ injuries.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Robert Brenner
Chief Operating Officer
John Wirthlin
Browse more venture capital transactions:
Prev: 4/2/2012: Ardica Technologies venture capital transaction
Next: 4/2/2012: MolecularMD venture capital transaction
Share this article
Where The Data Comes From
We do our best to document all VC transactions involving tech companies. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs